Inside this Book

If you make use of this material, you may credit the authors as follows:

Kahaly George J. (Editor), "70 Years of Levothyroxine", Springer Nature, 2021, DOI: 10.1007/978-3-030-63277-9, License: https://creativecommons.org/licenses/by/4.0/

This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals.

Keywords

Endocrinology, Pharmacology/toxicology, Pharmacology, Thyroid Gland, Hypothyroidism, Tsh, Thyroid Disorders, Metabolism, Open Access

Rights | License

Except where otherwise noted, this item has been published under the following license:

Takedown policy

If you believe that this publication infringes copyright, please contact us at info@jecasa-ltd.com and provide relevant details so that we can investigate your claim.